Literature DB >> 30910936

Authors' Reply.

Igor Denizarde Bacelar Marques1, Rosilene Motta Elias2, Rosa Maria Affonso Moysés2, Elias David-Neto3,2.   

Abstract

Keywords:  kidney disease; renal osteodystrophy; zoledronic acid

Mesh：

Substances：

Year:  2019        PMID： 30910936      PMCID： PMC6493990          DOI： 10.1681/ASN.2019020124

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  4 in total

1.  OPTN/SRTR 2016 Annual Data Report: Kidney.

Authors:  A Hart; J M Smith; M A Skeans; S K Gustafson; A R Wilk; A Robinson; J L Wainright; C R Haynes; J J Snyder; B L Kasiske; A K Israni
Journal:  Am J Transplant       Date:  2018-01       Impact factor: 8.086

2.  Chronic kidney disease is associated with low BMD at the hip but not at the spine.

Authors:  K S Bezerra de Carvalho; R F V Vasco; M R Custodio; V Jorgetti; R M A Moysés; R M Elias
Journal:  Osteoporos Int       Date:  2019-01-28       Impact factor: 4.507

3.  Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.

Authors:  N Segaud; I Legroux; M Hazzan; C Noel; B Cortet
Journal:  Osteoporos Int       Date:  2018-03-02       Impact factor: 4.507

4.  A Randomized Trial of Zoledronic Acid to Prevent Bone Loss in the First Year after Kidney Transplantation.

Authors:  Igor Denizarde Bacelar Marques; Maria Júlia Correia Lima Nepomuceno Araújo; Fabiana Giorgetti Graciolli; Luciene Machado Dos Reis; Rosa Maria R Pereira; Jackeline C Alvarenga; Melani Ribeiro Custódio; Vanda Jorgetti; Rosilene Motta Elias; Rosa Maria Affonso Moysés; Elias David-Neto
Journal:  J Am Soc Nephrol       Date:  2019-01-03       Impact factor: 10.121
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.